Potential Benefits of Sequential Inhibitor-Mutagen Treatments of RNA Virus Infections

Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides

(2009) M. H. Nguyen et al.   JOURNAL OF VIRAL HEPATITIS

Counteracting Quasispecies Adaptability: Extinction of a Ribavirin-Resistant Virus Mutant by an Alternative Mutagenic Treatment

(2009) Celia Perales et al.   PLoS One

Extremely High Mutation Rate of a Hammerhead Viroid

(2009) S. Gago et al.   SCIENCE

Lethal Mutagenesis of Picornaviruses with N-6-Modified Purine Nucleoside Analogues

(2008) J. D. Graci et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular strategies to inhibit the replication of RNA viruses

(2008) Pieter Leyssen et al.   ANTIVIRAL RESEARCH

Optimizing the Current Therapy for Chronic Hepatitis C Virus: Peginterferon and Ribavirin Dosing and the Utility of Growth Factors

(2008) Mitchell L. Shiffman   Clinics in Liver Disease

Stochastic extinction of viral infectivity through the action of defectors

(2008) J. Iranzo et al.   EPL

Future prospects for the treatment of rapidly evolving viral pathogens: insights from evolutionary biology

(2008) Esteban Domingo et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Avoiding therapeutic pitfalls: The rational use of specifically targeted agents against hepatitis C infection

(2008) Barbara H. McGovern et al.   HEPATOLOGY

Directly acting antivirals for the treatment of patients with hepatitis C infection: A clinical development update addressing key future challenges

(2008) Alex Thompson et al.   JOURNAL OF HEPATOLOGY

Repeated Bottleneck Transfers Can Lead to Non-cytocidal Forms of a Cytopathic Virus: Implications for Viral Extinction

(2007) Cristina Escarmís et al.   JOURNAL OF MOLECULAR BIOLOGY